Cells from young unrelated donors may be better for older patients

05/8/2013 | MDSBeacon.com

Older patients with myelodysplastic syndromes who received transplants of stem cells from younger matched but unrelated donors had fewer relapses and better five-year survival rates than patients who received cells from siblings or older matched but unrelated donors, according to a study in the journal Leukemia. The researchers reviewed the cases of 719 transplant recipients in Europe from 1999 to 2008.

View Full Article in:

MDSBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC